Research

Microbiome Research:

Our team investigates the role of the human microbiome in allergic diseases through 4 national and international collaborative studies. We have investigated how gut, skin, and respiratory tract microbiota influence immune responses and contribute to conditions like chronic rhinosinusitis, nasal polyposis, food allergy, asthma, eczema, and allergic rhinitis.

Environmental Factors and Allergies:

We delve into environmental triggers such as air pollution, pollen, and allergens. Our research aims to understand how these factors impact allergic disease development, exacerbation, and management.

Food Allergy Studies:

Our team is part of one of the largest ongoing cohort studies on food allergy. We explore mechanisms, diagnostic tools, epidemiological impacts, and management strategies for food allergy. Additionally, we collaborate with several prominent investigators across the globe on this topic.

Health Disparities in Allergic Diseases:

Recognizing that allergic conditions affect diverse populations differently, we have investigated health disparities and their detrimental impact on several allergic conditions. Our goal is to help identify, recognize, and address inequities in access to care, disease burden, and outcomes.

Cost-Effectiveness of Therapies:

We assess the economic impact of allergic disease management. By evaluating treatment options, our expert faculty aim to optimize cost-effective approaches while maintaining patient well-being.

Mitochondrial Diseases and Allergies:

One of our expert immunology faculty studies the links between mitochondrial dysfunction and immunologic manifestations, shedding light on the role of immune dysfunction in mitochondrial diseases.

Climate Change and Immunologic Diseases:

Given the changing climate, we study its effects on allergic and immunologic conditions. From pollen seasons to altered immune responses, we aim to understand, anticipate, and mitigate climate-related health challenges in our field.